<ѻýҕl>C3 Inhibitor Prevails in Trial of Rare Hemoglobinuriaѻýҕl> Improvement in hemoglobin, transfusion independence with pegcetacoplan for PNH Mar 17, 2021
<ѻýҕl>Time to Revisit Distant Nodal Status in Breast Cancer Curability?ѻýҕl> Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
<ѻýҕl>Holding tPA for All DOAC Users Not the Way to Go, Stroke Docs Sayѻýҕl> Clinical conundrum could be solved by a point-of-care DOAC test Mar 15, 2021
<ѻýҕl>Whole-Genome Sequencing Makes a Case in Leukemia Studyѻýҕl> More actionable alterations detected in myeloid malignancies versus cytogenetics Mar 10, 2021
<ѻýҕl>Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemiaѻýҕl> Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
<ѻýҕl>New Guideline Lowers Age to Begin Colorectal Cancer Screeningѻýҕl> Update comes as incidence has doubled in people under 50 Mar 09, 2021
<ѻýҕl>USPSTF Expands Lung Cancer Screening Criteriaѻýҕl> Lower age for starting, new definition of 'heavy smoker' double eligibility for screening Mar 09, 2021
<ѻýҕl>PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancerѻýҕl> No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
<ѻýҕl>Entrectinib Impresses in Certain Lung Cancersѻýҕl> Durable responses in most patients with advanced NSCLC, active in brain mets Mar 05, 2021
<ѻýҕl>Blincyto Shines for Kids' B-Cell ALLѻýҕl> Overall survival boost seen in new trials Mar 05, 2021
<ѻýҕl>New Targeted Therapies Show Promise in Cancerѻýҕl> Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<ѻýҕl>Mammo Study: One Saves Lives, More Exams Save More Livesѻýҕl> Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
<ѻýҕl>Neoadjuvant Dual ICI Leads to Clinical Benefit in Operable NSCLCѻýҕl> More than one-third of patients achieved major pathologic response with nivolumab-ipilimumab. Feb 18, 2021
<ѻýҕl>A CLEAR Upfront Winner in Advanced RCC?ѻýҕl> Pembrolizumab-lenvatinib makes splash with longest PFS benefit in RCC recorded to date Feb 14, 2021
<ѻýҕl>Practice-Changing Trial in Metastatic Papillary RCCѻýҕl> Cabozantinib improved PFS, response rates over sunitinib Feb 14, 2021
<ѻýҕl>New Standard in High-Risk Muscle-Invasive Bladder Cancer?ѻýҕl> Adjuvant nivolumab improves DFS in all comers, PD-L1 population Feb 13, 2021
<ѻýҕl>New Drug OK'd for Chemo-Induced Myelosuppression in SCLCѻýҕl> CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<ѻýҕl>CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancerѻýҕl> Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
<ѻýҕl>Survival Boost in Bladder Cancer With Antibody-Drug Conjugateѻýҕl> Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<ѻýҕl>Radionuclide Tx Wins in Third-Line Metastatic CRPCѻýҕl> Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
<ѻýҕl>Hit and Miss in Castration-Resistant Prostate Cancerѻýҕl> No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
<ѻýҕl>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻýҕl> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻýҕl>First Immunotherapy Approved for Basal Cell Carcinomaѻýҕl> Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<ѻýҕl>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancerѻýҕl> Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<ѻýҕl>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like?ѻýҕl> Agency staff skeptical of data in early breast cancer Feb 08, 2021
<ѻýҕl>Anti-CD20 Drugs Tied to Severe COVID in Cancer Patientsѻýҕl> Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
<ѻýҕl>Brain Tumor Risk Upped With Synthetic Progestogenѻýҕl> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻýҕl>Optimizing Neoadjuvant Therapy for Breast Cancerѻýҕl> ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<ѻýҕl>Dustin Diamond's Small Cell Lung Cancerѻýҕl> "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
<ѻýҕl>KRAS Inhibitor Continues to Impress in NSCLCѻýҕl> Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
<ѻýҕl>Nab-Paclitaxel as Possible Option for Relapsed NSCLCѻýҕl> Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
<ѻýҕl>AGA Updates Guidelines for Refractory H. Pyloriѻýҕl> New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
<ѻýҕl>Should COVID-Strained Centers Hit Pause on Lung Cancer Screening?ѻýҕl> A debate on what stopping scans would do to health systems, patients Feb 01, 2021
<ѻýҕl>Promising Data for Preop Checkpoint Inhibition in NSCLCѻýҕl> Major response rate of 21%, encouraging survival with single-agent atezolizumab Jan 31, 2021
<ѻýҕl>First-Ever Survival Bump in Relapsed Mesotheliomaѻýҕl> OS, PFS improved with nivolumab, but questions remain about alternatives, biomarkers Jan 30, 2021
<ѻýҕl>Dual Checkpoint Blockade No Help in PD-L1-High NSCLCѻýҕl> Single-agent pembrolizumab wins out as first-line therapy for advanced disease Jan 30, 2021
<ѻýҕl>COVID Affects Cancer Care, Patients' Mental Healthѻýҕl> Studies: fewer diagnoses, more severe disease, worse outcomes, distressed patients Jan 29, 2021
<ѻýҕl>Preventive Approach to C-Section Bleeding Pans Out in Trialѻýҕl> Treatment lowered risk of early blood loss and transfusion, but not more severe hemorrhage Jan 29, 2021
<ѻýҕl>Whole-Pelvis Tops Prostate-Only RT in High-Risk Diseaseѻýҕl> Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
<ѻýҕl>Officials Investigate Physician's Death After COVID Vaccinationѻýҕl> Onset of rare blood disorder should not be interpreted as causal, experts say Jan 27, 2021